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In this study, we explored the biocompatibility of Au nanoparticles (NPs) capped with peptide-biphenyl hybrid
(PBH) ligands containing glycine (Gly), cysteine (Cys), tyrosine (Tyr), tryptophan (Trp) and methionine (Met) amino
acids in the human hepatocellular carcinoma cell line Hep G2. Five AuNPs, Au[(Gly-Tyr-Met)2B], Au[(Gly-Trp-Met)2B],
Au[(Met)2B], Au[(Gly-Tyr-TrCys)2B] and Au[(TrCys)2B], were synthesised. Physico-chemical and cytotoxic properties
were thoroughly studied. Transmission electron micrographs showed isolated near-spherical nanoparticles with
diameters of 1.5, 1.6, 2.3, 1.8 and 2.3 nm, respectively. Dynamic light scattering evidenced the high stability of
suspensions in Milli-Q water and culture medium, particularly when supplemented with serum, showing in all cases
a tendency to form agglomerates with diameters approximately 200 nm. In the cytotoxicity studies, interference
caused by AuNPs with some typical cytotoxicity assays was demonstrated; thus, only data obtained from the
resazurin based assay were used. After 48-h incubation, only concentrations ≥50 μg/ml exhibited cytotoxicity. Such
doses were also responsible for an increase in reactive oxygen species (ROS). Some differences were observed
among the studied NPs. Of particular importance is the AuNPs capped with the PBH ligand (Gly-Tyr-TrCys)2B
showing remarkable stability in culture medium, even in the absence of serum. Moreover, these AuNPs have
unique biological effects on Hep G2 cells while showing low toxicity. The production of ROS along with supporting
optical microscopy images suggests cellular interaction/uptake of these particular AuNPs. Future research efforts
should further test this hypothesis, as such interaction/uptake is highly relevant in drug delivery systems.
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At the forefront of many lines of research in drug delivery
are the endless possibilities of gold nanoparticles (AuNPs)
[1-4]. These molecules are readily taken up by cells, and
they therefore provide a valuable means for drug delivery,
with reports of efficient transport across the blood–brain
barrier in mice [5] and nuclear penetration in the human
HeLa cell line [6]. At nanoscale, the properties conferred
upon such an otherwise inert metal in its bulk form are
surprising. It is precisely these unique properties that offer
potential in fields as diverse as diagnostics, anti-cancer
therapies, catalysts and fuel cells. One avenue that has been* Correspondence: yolanda.cortes@urjc.es; fcruz@inia.es
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in any medium, provided the original work is pstudied exhaustively in recent years is the use of coatings
and capping agents in the rational design of NPs, both to
stabilise and functionalise these nanoparticles. Specific cap-
ping agents can lead to the self-assembly of NPs into or-
dered ‘superstructures’ creating different shapes [7], and by
altering the capping structure, different arrangements can
be achieved. In terms of biocompatibility, when using a
polyvinyl alcohol capping agent, AuNPs do not show tox-
icity in zebrafish, despite being taken up into embryos and
evidence of bioaccumulation [8]. These observations high-
light the use of capping agents as an approach to achieve
safer NPs. We recently proposed the use of peptide-
biphenyl hybrid (PBH) ligands as capping agents [9]. PBHs
have a biphenyl system and two amino acid/peptide frag-
ments, and they present key characteristics, such as dy-
namic properties in solution [10], ordered structures in the
solid phase [11] and biological activity as calpain inhibitors
[12]. Some of these properties arise from the presence ofs an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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to participate in a variety of non-covalent bonds, including
hydrogen bonds [13,14] and arene interactions [15,16]. In
addition, the conformational flexibility around the aryl-aryl
single bond allows the PBH to adopt its structure in order
to obtain the most favourable interactions with other
chemical species, thus achieving high biological activity
[17]. In peptidomimetics, this approach is considered a
novel way to tailor NPs to have desired physico-chemical
properties, which could contribute, for example, to ad-
vances in biomedical applications for AuNPs as drug deliv-
ery systems. A molecule can be designed in such a way as
to benefit from structure-activity relationships and to attain
higher levels of stability and/or biocompatibility. In a study
on the design of peptide capping ligands for AuNPs, Lévy
et al. [18] reported that peptide chain length, hydrophobi-
city and charge strongly influence NP stability. Here, we
capped AuNPs with various PBH ligands and studied how
the ligand structures influence the stability and the physico-
chemical properties of the AuNPs under cell culture condi-
tions and how they affect the biological response.
The huge discrepancies in reports on NP toxicity may
be related to their different stabilities under various ex-
perimental conditions, leading to distinct physico-
chemical properties that directly influence the effect of
these particles. Given the unique and unpredictable be-
haviour of NPs in different environments [19,20], we
performed a detailed physico-chemical analysis, a pre-
requisite for any NP toxicity study. Distinct NP proper-
ties, such as size, shape, aggregation state, zeta potential
and dispersibility, along with the inherent composition
of the NPs themselves, all influence the degree of tox-
icity [21-23]. To study the interaction between these
PBH-capped AuNPs and biological systems, we under-
took cytotoxicity studies. Many articles have demon-
strated a close relationship between size and toxicity for
AuNPs [24,25]. Findings suggest that size not only can
influence uptake but may also dictate the possible inter-
action with DNA grooves [26,27], thus leading to AuNPs
of different sizes showing distinct mechanisms of tox-
icity. For instance, AuNPs of 1.4 and 1.2 nm in diameter,
thus differing by only 0.2 nm, show different pathways
of toxicity in HeLa human cervix carcinoma cell lines,
causing cell death by necrosis and apoptosis, respectively
[28]. AuNPs have reported LC50 values of 65 to 75 μg/
ml in Daphnia magna [29]. According to Farkas et al.
[30], these particles are potent inducers of reactive oxy-
gen species (ROS) in rainbow trout hepatocytes, with
concentrations of 17.4 μg/ml increasing ROS production
threefold as early as 2 h post-exposure. However, there
have also been reports of AuNP biocompatibility,
suggesting cell-selective responses following AuNP ex-
posure that may be related to specific mechanisms of
toxicity. Cell death through apoptosis has been reportedin the human lung carcinoma cell line A549 after expos-
ure to AuNPs, with no evidence of cytotoxicity in BHK21
(baby hamster kidney), Hep G2 (human hepatocellular
liver carcinoma) or MDCK (canine epithelial kidney) cell
lines [31,32]. These observations may be explained by
AuNP interaction with cellular stress response mecha-
nisms on a genetic level [33], which may dictate the cells
capacity to prevent cytotoxic effects.
To further our understanding of AuNP interaction with
biological systems and the properties that may govern bio-
compatibility, after performing a detailed physico-chemical
characterisation of all the PBH-capped AuNPs, we used an
in vitro approach to assess the possible toxic effects and the
oxidative stress potential of these particles. We focused on
how the structure of the capping PBH used affects NP size
and stability over time under a range of conditions in vitro.
Differences in NP behaviour when suspended in cell culture
medium with serum and without serum were examined.
This approach allowed us to compare any changes in the
physico-chemical properties of the NPs that may be associ-
ated with the interaction of the agent with fetal bovine
serum and protein coating. Given that the liver is one of
the main sites of AuNP bioaccumulation following intra-
venous injection [34,35]; we chose a human hepatocellular
carcinoma cell line (Hep G2) as the most appropriate and
relevant test system. NPs have been described to interfere
with assays, and some reviews report the limitations of cer-
tain assay systems [36] and that AuNPs even have the cap-
acity to quench or enhance fluorescence depending on the
plasmon field and dipole energy [37]. Also, gold can bind
biological thiols such as glutathione [38,39]. Therefore, in
this study, close attention was paid to any potential interfer-
ence of AuNPs with the assay systems.Methods
Chemicals and reagents
The synthesis and characterisation of PBHs are de-
scribed in detail in Additional file 1. The chemicals used
for AuNP synthesis, such as hydrogen tetrachloroaurate
(III) trihydrate (HAuCl4∙3H2O), sodium borohydride
(NaBH4), ethanol, 2-propanol and dimethyl sulfoxide-d6
were purchased from Sigma-Aldrich (Madrid, Spain).
For biocompatibility studies, Eagle’s minimum essen-
tial medium (EMEM), ultra glutamine 1 (200 mM in
0.85% NaCl solution), non-essential amino acids 100 X
(NEAA), fetal bovine serum (FBS), penicillin/strepto-
mycin (10,000 U/ml/10 mg/ml) and trypsin EDTA (200
mg/l EDTA, 17,000 U trypsin/l) were all sourced from
LONZA (Barcelona, Spain). MEM and EMEM without
phenol red were purchased from PAN Biotech GmbH
(Aidenbach, Germany). High-grade purity water (>18
MΩ cm) obtained from a Milli-Q Element A10 Century
(Millipore Iberia, Madrid, Spain) was used in all the
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Sigma-Aldrich.Synthesis of AuNPs
Five AuNPs, (Au[(Gly-Trp-Met)2B], Au[(Gly-Tyr-TrCys)2B],
Au[(Gly-Tyr-Met)2B], Au[(Met)2B] and Au[(TrCys)2B])
(Figure 1), were synthesised following the methodology
described by Pérez et al. [9] (see Additional file 1). Thus,
each PBH (50 μmol) was dissolved in ethanol (20 ml,
2.5 mmol/l) and was added to a solution of HAuCl4 (50 ml,
0.5 mmol/l) in 2-propanol under stirring. After 30 min,
a freshly prepared aqueous solution of NaBH4 (4 ml,
50 mmol/l) was added slowly. The mixture was stirred
for 2 h at room temperature to afford a red-brown col-
loidal gold solution. The AuNPs were precipitated by
centrifugation for 15 min at 6,000 rpm. The black-
brown precipitate was washed with 2-propanol to re-
move the free ligand and then dried under vacuum. The
PBH-capped AuNPs obtained were stable to some cy-
cles of precipitation and re-dispersion and could be eas-
ily dispersed in water.
Physico-chemical characterisation of AuNPs
Transmission electron microscopy
Transmission electron microscopy (TEM) images of the
synthesised AuNPs were obtained using a Philips Tecnai 20
operating at 200 kV (FEI, Eindhoven, The Netherlands).
AuNPs were also examined after their suspension in culture
medium without serum (EMEM/S-) at time 0 and 24 h
using a LEO-910 microscope (Carl Zeiss, Oberkochen,
Germany) operating at an accelerating voltage of 80 kV and
equipped with a digital camera Gatan Bioscan 792 (Gatan
Inc., Pleasanton, CA, USA). The samples for TEM charac-
terisation were prepared by placing and evaporating a drop
of the AuNPs in 2-propanol, or in medium, on carbon-Figure 1 Peptide-biphenyl hybrid (PBH) ligands used in this study, Trcoated copper grids (200 mesh). Average particle sizes were
obtained by measuring the diameters of 150 particles.
Nuclear magnetic resonance
1H nuclear magnetic resonance (NMR) and 13C NMR
spectra were recorded on Varian Mercury-400 and
Varian Inova-300 instruments (Agilent Tecnologies,
Santa Clara, CA, USA). Chemical shift (δ) constants are
indicated in hertz. 1H NMR spectra were referenced to
the chemical shift of TMS (δ = 0.00 ppm). 13C NMR
spectra were referenced to the chemical shift of the deu-
terated solvent. The following abbreviations are used to
explain multiplicities: s = singlet, d = doublet, t = triplet,
q = quartet, m = multiplet, br = broad. The spectra of
the ligands and the AuNPs were collected in dimethyl
sulfoxide-d6 (DMSO-d6).
Elemental analysis
The amount of PBH capped on the AuNPs was esti-
mated by elemental analysis of C, H, N and S. Combus-
tion analyses were performed on an EA 1180-Elemental
Analyzer (Carlo Erba, Milan, Italy).
Fourier transform infrared spectroscopy
Fourier transform infrared (FT-IR) spectra in the range
of 600 to 4,000 cm−1 were recorded using a Nicolet-550
FT-IR spectrophotometer (Thermo Fisher, Hudson, NH,
USA). The analysis was done in the solid state. Thirty-
two scans were used to record the IR spectra.
UV–vis spectroscopy
Ultraviolet–visible (UV–vis) spectroscopy measurements
of the AuNP samples were recorded on a Cary-500 spec-
trophotometer (Agilent Tecnologies, Santa Clara CA,
USA) within the range 300 to 900 nm. The samples were
prepared, using water as solvent, at 100 μg/ml. UV–vis= Trityl, B = 2, 2’-(bis)carbonylbiphenyl.
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AuNPs in EMEM/S+ and EMEM/S- at a concentration
of 100 μg/ml and at time-point 0 and 2, 4 and 24 h after
incubation at 37°C.
Dynamic light scattering
Dynamic light scattering (DLS) was used to determine the
hydrodynamic size of NPs in solution, using a Zetasizer
Nano-ZS (Malvern Instruments Ltd., Worcestershire,
UK). Measurements of the hydrodynamic size of the NP
suspensions (100 μg/ml) in Milli-Q water and in EMEM
biological medium with serum (EMEM/S+) and without
serum (EMEM/S-) were taken at time 0 and at 24 h under
exposure conditions (37°C and 5% CO2). Careful attention
was paid to distinguish measurements of background
serum proteins from NP agglomerates in suspensions pre-
pared in EMEM/S+. In addition, to study stability over
time and the state of particles during the cell exposure
timeframe in EMEM/S-, we conducted a kinetic study.
DLS measurements were taken directly after the AuNPs
were suspended (time 0) and at 2, 4, 24 and 48 h of incu-
bation in exposure conditions. Three independent analyses
were performed, and the mean ± standard deviation (SD)
was used to represent results. Four measurements were
taken in each independent analysis, with each measure-
ment consisting of six runs, each lasting 10 s. The average
from each of these measurements was calculated using
Zetasizer series software 6.20 (Malvern Instrument). The
instrument was set to automatically select the best condi-
tions for measurements. A kinetic study was not performed
in EMEM/S+ because of evidence of a stable suspension
from time 0 to 24 h under exposure conditions when
serum was present.
Zeta potential
Zeta potential measurements were performed to determine
the stability of the PBH-capped AuNPs in Milli-Q water
and in the different medium suspensions (EMEM/S+ and
EMEM/S-). A Malvern Zetasizer Nano-ZS and folded ca-
pillary cells (Malvern Instruments Ltd., Worcestershire,
UK) were used. One-millilitre aliquots of AuNP suspen-
sions (100 μg/ml) were taken directly after preparation and
24 h after incubation in the different media. Due to the
limitations of high salt content in both medium suspen-
sions, zeta potential measurements were performed only in
Milli-Q water. Three independent measurements were
taken, and the mean ± SD is presented.
Optical microscopy and visual sedimentation of
AuNP suspensions
An inverted light microscope Axiovert 25 (Carl Zeiss,
Madrid, Spain) equipped with a Canon EOS 1000D
(Canon, Madrid, Spain) camera was used to take images.
NP suspensions (0.781 to 100 μg/ml) were prepared inEMEM/S+ and EMEM/S- medium, and 100-μl aliquots of
each concentration were suspended in 96-well plates. Sus-
pensions were viewed 24 h after incubation in exposure
conditions (37°C/5% CO2). A recent study carried out by
Cho et al. [40] highlights the importance of considering
sedimentation when carrying out NP toxicity studies
in vitro. Those authors reported that different concentra-
tions of NPs in the bottom of culture plates or ‘interaction
zones’ caused by distinct ratios of sedimentation to diffu-
sion velocities can result in variations in uptake. To detect
differences in dispersion and sedimentation between
the PBH-capped AuNPs in EMEM/S+ and EMEMS/S-
medium, photographs were taken of the AuNP suspen-
sions (100 μg/ml) in 1.5-ml tubes after 24-h incubation
under exposure conditions.
Cell culture and AuNP exposure
Human liver hepatocellular carcinoma cells (Hep G2) were
from the American Type Culture Collection (Manassas,
VA, USA). These cells were cultured in EMEM medium
supplemented with 10% FBS, 1% penicillin/streptomycin,
1% ultraglutamine and 1% NEAA. They were incubated at
37°C with 5% CO2 in a humidified incubator. For AuNP
exposure, cells were plated at densities of 7.5 × 104 cells
per millilitre in 96-well tissue culture microtiter plates
(Greiner-Bio one, CellStar, Madrid, Spain) and subse-
quently incubated for 24 h. After this period, cells were ex-
posed to a series of concentrations of the five AuNP
preparations for either 2 or 24 h for ROS production stud-
ies or for 24 or 48 h for the cytotoxicity studies. AuNP sus-
pensions were prepared in high-grade Milli-Q water to
achieve a stock concentration of 1,000 μg/ml. All stock
preparations were stored at 4°C. AuNP working concentra-
tions were prepared from the 1,000 μg/ml stock prepara-
tions in EMEM/S + or EMEM/S-. Given the different size
and stability profiles found for the AuNPs when suspended
in these two types of medium, as shown by UV–vis, DLS
and TEM analysis, we performed exposures in medium
with and without serum. Working concentrations ranged
from 0.781 to 100 μg/ml and were prepared using serial
half dilutions. The final concentration of water in EMEM
medium did not cause any osmotic imbalance. For each
assay, three independent experiments were performed,
with exposures carried out in triplicate for each concentra-
tion. Untreated cells in culture medium were used as nega-
tive controls in all experiments, while a serial half dilution
of chloramine-T was used to produce a concentration
range between 0.325 and 10 mmol/l, which was used as a
positive control.
Toxicity studies
Interference of AuNPs in toxicity assays
NP suspensions of each concentration tested were pre-
pared in EMEM medium, phosphate-buffered saline
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or MEM phenol red-free medium, depending on the
assay system being used, and included in the assay as an-
other control to check possible AuNP absorbance at the
corresponding wavelengths. Very high dose-dependent
interferences were observed at the wavelengths used for
the methyl thiazol tetrazolium (MTT) and neutral red
uptake assay (NRU) assays. Some measurements were
carried out after washing the cells to determine if this
washing could lead to a reduction in the number of
remaining AuNPs and consequently in the interference.
We also examined whether the AuNPs used in this study
interacted with glutathione. For that, a cell-free experi-
ment was set up in which a constant concentration (8
μmol/l) of glutathione was incubated with a range of
AuNP concentrations for 2 h. The glutathione content
was then measured as described below.
Cytotoxicity
Methyl thiazol tetrazolium and neutral red uptake
assays The MTT [(4,5-dimethylthiazoyl-2-yl)-2,5-diphe-
nyltetrazolium bromide)] reduction assay, based on the
conversion of tetrazolium salts to formazan crystals, was
used to evaluate cell viability on the basis of mitochondrial
activity, following the method described by Mosmann [41].
The NRU assay was used to determine the accumulation of
neutral red dye in the lysosomes of viable, uninjured cells
[42]. After the 24-h exposure, cells were incubated for 3 h
with 500 μg/ml MTT reagent or for 2 h with 100 μg/ml
neutral red dye, depending on the assay being performed.
The resulting formazan crystals and remaining neutral red
dye were dissolved with isopropanol or 1% glacial acetic
acid in 50% ethanol, respectively. The absorbance of each
well was read at 550 and 570 nm for the NRU and MTTas-
says, respectively, using a Tecan GENios plate reader
(Tecan Group Ltd., Männedorf, Switzerland).
Resazurin assay The method described by O’ Brien et al.
[43], based on the reduction of resazurin to resorufin by
mitochondrial oxidoreductases, was used. Cells were ex-
posed to the AuNPs for 24 h, suspensions were removed,
and cells washed with PBS and then treated with 20% (v/v)
of resazurin dye reagent prepared in EMEM medium. The
plate was then placed in a 37°C/5% CO2 incubator for 2 h,
after which the fluorescence intensity was read at 532-nm
excitation and 595-nm emission wavelengths using a Tecan
GENios plate reader. Results are represented as a percent-
age of the control. To study whether there was any further
reduction in viability, cytotoxicity was also analysed after
48 h of exposure.
Images of cell condition At 2 and 24 h of exposure, im-
ages of the cells treated with NPs were taken and analysed
for signs of cytotoxicity. An inverted light microscope(Axiovert 25, Carl Zeiss) equipped with a camera was used
to take images. Evidence of cytoskeleton rounding or a
change in normal shape compared to untreated controls
was regarded as a sign of cytotoxicity. Also, to determine
the degree of cytotoxicity, we compared the morphology
of cultured cells with that of cells exposed to the positive
control chloramine-T.
Oxidative stress
Quantification of reactive oxygen species Intracellular
ROS production was determined using the dichlo-
rofluorescein (DCF) assay [44]. Stock aliquots of 2’, 7’-
dichlorofluorescein diacetate (DCFH-DA) were prepared
in dimethyl sulfoxide (DMSO) (100 mM) and diluted
1:1,000 in MEM phenol red-free medium to a final con-
centration of 100 μM, 0.1% (v/v) DMSO. After the ex-
posure period (2 or 24 h), the medium and exposure
compounds were removed, and cells were washed with
PBS. Next, 100 μM of DCFH-DA probe was added to each
well. The plate was incubated at 37°C/5% CO2 in the dark
for 30 min. After the incubation period, the DCFH-DA
probe was removed, and the cells were washed twice with
PBS. MEM phenol red-free medium was then added to the
cells, and the fluorescence was measured at 485-nm excita-
tion and 535-nm emissions (Tecan GENios plate reader).
Fluorescent readings were taken immediately (time 0) and
every 15 min over 60 min, with the plates maintained
under dark conditions and incubated under exposure con-
ditions (37°C/5% CO2) between measurements. ROS pro-
duction was calculated as the percentage increase in
fluorescence per well over a 60-min period using the for-
mula [(Ft60 − Ft0)/Ft0 × 100], where Ft60 and Ft0 are the
fluorescence measured at time 60 and 0 min, respectively.
This result was finally expressed as percentage of the
control.
Reduced glutathione/oxidised glutathione ratio The
assay protocol was set up based on the optimised microti-
ter plate method used by Allen et al. [45]. Following the
24-h exposure, cells were lysed, and 50 μl of PBS was then
added to each well. Twenty-five microlitres of cell suspen-
sion was transferred to a new 96-well plate and used to
assay for protein content. To the other 25 μl of lysed cells,
we added 50 μl of ice-cold 5% (w/v) SSA diluted in Milli-
Q water in order to remove any interfering proteins from
the sample. Of this suspension, 25 μl was used to assay for
total glutathione (reduced glutathione + oxidised glutathi-
one ratio - GSH + GSSG) content, while the other 25 μl
was treated with 4-vinylpyridine 0.5 μmol/l, a scavenger of
GSH, to assay the GSSG content. One hundred twenty-
five microlitres of reaction buffer (PBS 143 mmol/l
containing 6.3 mmol/l EDTA at pH 7.4, 229 U/ml GSH
reductase, 2.39 mmol/l β-nicotinamide adenine dinucleo-
tide phosphate (NADPH) and 0.01 mol/l 5, 5’-dithiobis (2-
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suspension. The conversion of DTNB to 5’-thiol-2-
nitrobenzoic acid (TNB) by the oxidation of GSH to GSSG
was monitored by measuring absorbance at 405 nm every
min over 10 min using a Tecan GENios plate reader. The
rate of conversion, measured by the slope of the curve,
was proportional to the concentration of glutathione in
the sample. A standard curve with different concentra-
tions of GSSG was used to calculate the glutathione con-
tents in the samples.
Statistical analysis
For all the assays used, we performed three independent
experiments with exposures carried out in triplicate for
each concentration. The values shown are expressed as
mean ± standard error of the mean (SEM). Sigma Plot
12 software (Systat Software Inc, CA, USA) was used for
statistical analysis. The normality of the distribution was
checked by means of the Shapiro-Wilk test. Equal vari-
ance was not assumed by the software and was tested
(F test). A one-way repeated measures analysis of variance
(RM-ANOVA) was carried out, followed by a post hoc
Dunnett’s test with P < 0.05 or P < 0.01.
Results
Physico-chemical characterisation of PBH-capped AuNPs
The AuNPs were synthesised using PBHs as capping li-
gands (Figure 1). In a previous study [9], we used PBHs
containing cysteine (Cys), tyrosine (Tyr) and glycine
(Gly) amino acids to form stable AuNPs: Au[(TrCys)2B]
and [(Gly-Tyr-TrCys)2B]. In the present study, we dem-
onstrate that the amino acids methionine (Met) and
tryptophan (Trp) are also useful to prepare stable
functionalised AuNPs such as Au[(Met)2B], Au[(Gly-
Tyr-Met)2B] and Au[(Gly-Trp-Met)2B]. TEM images of
the PBH-capped AuNPs and the corresponding size dis-
tribution histograms are shown in Figure 2. The micro-
graphs show isolated near-spherical NPs with diameters
of 1.5, 1.6, 2.3, 1.8 and 2.3 nm for Au[(Gly-Tyr-Met)2B],
Au[(Gly-Trp-Met)2B], Au[(Met)2B], Au[(Gly-Tyr-TrCys)
2B] and Au[(TrCys)2B], respectively. The NPs stabilised
with the bulkiest PBHs were smaller. This observation
may be attributable to the steric bulk of the ligand con-
trolling NP growth.
TEM images combined with elemental analysis were
used to estimate the molecular formula of the PBH-
capped AuNPs (Table 1). The AuNPs prepared with
PBHs containing Met residue were stabilised with a
lower number of ligands on each AuNP surface com-
pared to the AuNPs capped with other PBH ligands. A
direct comparison of Au[(Met)2B] and Au[(TrCys)2B] re-
vealed fewer ligands for the Met-containing PBH-AuNP,
despite both having the same diameter. 1H NMR spectra
and FT-IR absorption spectra of free PBHs and of thePBH-capped AuNPs were measured to identify the inter-
actions between the gold surface and the capping ligand.
The NMR spectra of the AuNPs showed broad signals
compared to the free PBHs. Figure 3 shows 1H NMR
spectra of Au[(Gly-Tyr-Met)2B] and its free PBH (Gly-
Tyr-Met)2B in DMSO-d6. The signal of the H-α of the
Met residue appeared at approximately 1.5 ppm in the
PBH (Gly-Tyr-Met)2B NMR spectrum and was signifi-
cantly broadened in that of Au[(Gly-Tyr-Met)2B]. A
similar line broadening was also observed in the NMR
spectrum of Au[(Gly-Trp-Met)2B] (Figure 3) and of Au
[(Met)2B] (see Additional file 2: Figure S1). These obser-
vations indicate that the PBH was attached to the gold
surface through the Met residue [46]. Analogous results
were observed for the NMR spectra of Au[(Gly-Tyr-
TrCys)2B] and Au[(TrCys)2B] [9], where the sulphur
atom of the TrCys residue is involved in the surface
binding.
The FT-IR spectra are shown in Figure 4. For Au
[(Gly-Tyr-Met)2B], Au[(Gly-Trp-Met)2B] and Au[(Met)
2B], the band caused by the C = O stretching mode of
the carboxylic group was absent. However, two bands
were observed around 1,600 and 1,398 cm−1, assigned to
the asymmetric and symmetric stretching vibrations of
carboxylate anions [48]. These results suggest that the
carboxylic groups are also involved in PBH interactions
with the gold surface. Significant changes were observed
in the amide I band in the spectra of capped NPs com-
pared with those of the free PBHs. For Au[(Gly-Tyr-
Met)2B] and Au[(Gly-Trp-Met)2B], the amide I band red
shifted to 1,639 and 1,649 cm−1, respectively, however,
the amide band II appeared in the same position at
1,515 and 1,523 cm−1, respectively. For Au[(Met)2B], the
band assigned to amide I blue shifted to about 1,600 cm−1
and the amide II band red shifted to 1,543 cm−1. These
findings indicate that conformational changes occur in the
structure of the capping ligands attached to the NPs. Simi-
lar conclusions were drawn from the IR spectra of Au
[(Gly-Tyr-TrCys)2B] and Au[(TrCys)2B] [9].
Physico-chemical characterisation of PBH-capped AuNPs
under culture conditions
UV–vis absorption spectroscopy
Figure 5 shows the UV–vis absorption spectra of AuNPs
in Milli-Q water at time 0 and in EMEM/S- taken at
different time points under assay conditions (37°C and
5% CO2). The spectrum in water, at a concentration of
100 μg/ml, shows the surface plasmon resonance (SPR)
band in the range of 505 to 519 nm, characteristic of col-
loidal gold. The position of the SPR band was established
as a function of particle size, stabilising ligand and solvent
dielectric [49]. The SPR band of the UV–vis spectra of
AuNPs (100 μg/ml) in EMEM/S- changed over time.
The UV–vis spectra of the AuNPs after 24-h incubation
Figure 2 TEM images and size histograms of PBH-capped AuNPs. (a) Au[(Gly-Trp-Met)2B], (b) Au[(Gly-Tyr-TrCys)2B], (c) Au[(Gly-Tyr-Met)2B],
(d) Au[(Met)2B] and (e) Au[(TrCys)2B] [Scale bars: 10 nm for (a) and (b); and 5 nm for (c), (d) and (e)].
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range of 550 to 800 nm, indicating the aggregation of
NPs in EMEM/S- medium as a result of the presence of
salts in the medium. The band was also red shifted to
525 nm, in the case of Au[(Gly-Trp-Met)2B] and Au
[(Gly-Tyr-Met)2B], and close to 560 nm for Au[(Gly-
Tyr-TrCys)2B], Au[(Met)2B] and Au[(TrCys)2B]. Thered shift of the SPR band can be induced by a change in
the refractive index that surrounds the AuNPs or by
aggregation of NPs [50] caused by the presence of
chemical or biological analytes in the culture medium.
In addition, in the case of Au[(Gly-Trp-Met)2B], Au
[(Gly-Tyr-Met)2B] and Au[(Met)2B], which contain me-
thionine, a minimal decrease in the intensity band was
Table 1 Structural characteristics of the AuNPs from elemental analysis and TEM data
AuNP Size (nm) Calculated m/na from %Nb Number of Au atomsc PBH units per Au nanoparticle Mw
Au[(Gly-Trp-Met)2B] 1.6 0.062 126 8 32,106
Au[(Gly-Tyr-TrCys)2B] 1.8 0.22 180 40 90,397
Au[(Gly-Tyr-Met)2B] 1.5 0.064 104 7 27,100
Au[(Met)2B] 2.3 0.154 375 57 102,625
Au[(TrCys)2B] 2.3 0.26 375 97 164,377
Bold emphasis is used to signal the most stable AuNP; am, Number of PBH units; n, Number of Au atoms; b%N from elemental analysis; cestimated supposing
spherical particles and applying N = 30.89602 D3 [47].
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structure and optical properties of gold. The amino acids
of the culture medium were adsorbed on the surface of
Au[(Gly-Trp-Met)2B], Au[(Gly-Tyr-Met)2B] and Au[(Met)
2B], and this effect might mask the optical absorption of
these NPs [51]. AuNPs containing methionine were
stabilised with a lower number of ligands and may have
the capacity to link more molecules of amino acid on their
surfaces. In comparison, the UV–vis spectra of AuNPs in
EMEM/S+ (100 μg/ml) (see Additional file 3: Figure S2)
did not show any change in the range of 550 to 800 nm.
These spectra revealed no noticeable aggregation in prepa-
rations of AuNPs in EMEM/S+. Nevertheless, some de-
creases in the band intensities occurred over time in all
cases, thereby indicating the adsorption of serum proteins
from the medium [52].
Zeta potential
To study changes in AuNP stability, on the basis of elec-
trostatic interaction, zeta potential measurements were
performed. Due to the high salt content of EMEM/S+ and
EMEM/S- media, measurements were performed only in
Milli-Q water. Measurements were taken just after prepar-
ation of AuNP suspensions (100 μg/ml), at initial time
(T0) and 24 h after incubation under assay conditions.
The five AuNP preparations used in this study, namely Au
[(Gly-Trp-Met)2B], Au[(Gly-Tyr-TrCys)2B], Au[(Gly-Tyr-
Met)2B], Au[(Met)2B] and Au[(TrCys)2B], showed zeta po-
tentials of −31.6 ± 2.02, −37 ± 1.04, −36 ± 1.12, −39 ± 1.07
and −43.3 ± 1.13 mV, respectively (Table 2). All zeta po-
tentials were negative and remained negative over time.
DLS was used to measure the hydrodynamic diameters
of NPs in Milli-Q water and in medium suspension
(100 μg/ml). DLS measurements were taken just after sus-
pension (T0) and after 24 h incubations (T24) under assay
conditions. In water, all AuNP preparations formed ag-
glomerates, showing characteristic maximum intensity
hydrodynamic diameters of ≤200 nm (Table 2). The Au
[(Gly-Tyr-Met)2B] also appeared as larger agglomerates,
with a maximum intensity diameter of 591 nm at time 0,
while Au[(Met)2B] presented an additional NP population
of only 38 nm in diameter. Using the size distribution of
the AuNPs in water as a reference, we observed anincrease in hydrodynamic size for all the AuNP prepara-
tions when incubated in EMEM/S+ and EMEM/S-, but to
different extents. The average increase in hydrodynamic
size for all the NP preparations in EMEM/S+ was 85 ±
26 nm at time 0 (Table 2). An exception was AuNPs Au
[(Met)2B], which did not increase in size in this medium.
Also, with respect to the other three NPs, the larger
agglomerates of Au[(Gly-Tyr-Met)2B] underwent a much
larger increase in size from 591 to 987 nm. The hydro-
dynamic sizes of Au[(Gly-Trp-Met)2B] in water and
EMEM/S+ are noticeably smaller than found for Au[(Gly-
Tyr-Met)2B]. These differences could be attributed to the
presence, in the PBH ligand (Gly-Trp-Met)2B, of the add-
itional anchoring site, indole NH group of the Trp reside,
which may be contributing to the stabilisation of this nano-
particle. All AuNP preparations remained in the same state
in water and EMEM/S+ over 24 h, with no change in their
size distribution profiles from those measured directly after
preparation (Table 2). In contrast, for AuNPs incubated in
EMEM/S-, a time-dependent increase in size was detected
(Table 2). At time 0 (T0), the average increase in size in
EMEM/S- was 86 ± 21 nm, similar to the distribution of
most PBH-capped NPs in EMEM/S+, except Au[(Met)2B],
which experienced extensive agglomeration at time 0
(1,568 nm) with smaller fluctuations in its maximum
hydrodynamic diameter over 24 h in EMEM/S- (1,368 nm).
The Au[(Gly-Trp-Met)2B], Au[(Gly-Tyr-Met)2B] and Au
[(TrCys)2B] showed a time-dependent increase in size dis-
tribution, represented by agglomerates of 1,239, 1,230 and
908 nm after 24 h of incubation, respectively (Table 2). Au
[(Gly-Tyr-TrCys)2B] was the only preparation of AuNP that
remained in the same relative size distribution profile over
time and with the same maximum intensity hydrodynamic
diameter (±54 nm) after a 24-h incubation in EMEM/S-. A
kinetic study was performed to monitor changes in the
AuNP suspensions (100 μg/ml) over time (Figure 6). DLS
measurements were taken just after NP suspension in
EMEM/S- and after 2-, 4-, 24- and 48-h incubations under
assay conditions. The size distribution profiles for each
preparation in EMEM/S- at each time point are repre-
sented in Figure 6, which shows an increasing tendency of
agglomeration for all the AuNPs, except Au[(Gly-Tyr-
TrCys)2B], which remained stable over time.
Figure 3 1H NMR spectra of free PBHs and PBH-capped AuNPs. (a) Free PBH (Gly-Tyr-Met)2B (top) and
1H NMR spectrum of AuNP Au[(Gly-
Tyr-Met)2B] (bottom) in DMSO-d6, and (b)
1H NMR spectrum of free PBH (Gly-Trp-Met)2B (top) and
1H NMR spectrum of AuNP Au[(Gly-Trp-Met)2B]
(bottom) in DMSO-d6.
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Transmission electron micrographs were taken of the
PBH-capped AuNPs after suspension in EMEM/S-
medium (T0) and after 24 h of incubation (T24) under
assay conditions (37°C/5% CO2). Representative TEM im-
ages of Au[(Gly-Tyr-TrCys)2B], Au[(TrCys)2B] and Au
[(Gly-Tyr-Met)2B] are shown in Figure 7. Figure 7a,c shows
TEM micrographs of Au[(TrCys)2B] and Au[(Gly-Tyr-
TrCys)2B] directly after suspension, respectively. Both im-
ages reveal isolated NPs with the same size (1 to 3 nm) in
the absence of medium. After 24 h of incubation, Au[(Gly-
Tyr-TrCys)2B] and Au[(TrCys)2B] (Figure 7b,d) showed ag-
glomeration and a clear interaction of individual NPs with
medium components, as determined from TEM images. By
comparing the micrographs, the highest degree of agglom-
eration in the case of Au[(Gly-Tyr-Met)2B] (Figure 7e,f)
after suspension in medium can be appreciated. Therefore,
one would expect the surface chemistry of these NPs upon
interaction with media not to be the same as for the NPs
initially prepared [53].
Optical microscopy and visual sedimentation of AuNP
suspensions
Large distinctive agglomerates of micrometre scale were
observed for all AuNP preparations when viewed underan optical microscope (Figure 8), with the exception of
Au[(Gly-Tyr-TrCys)2B] (Figure 8b). Also upon visual ob-
servation of the AuNP suspensions in the different
medium suspensions after 24 h of incubation, we made
some key observations regarding sedimentation over
time. After 24 h of incubation in EMEM/S-, Au[(Gly-
Trp-Met)2B], Au[(Gly-Tyr-Met)2B], Au[(Met)2B] and Au
[(TrCys)2B] sedimented out of solution, as determined by
the presence of a pellet at the bottom of the tubes. Au
[(Gly-Tyr-TrCys)2B] remained dispersed in solution, hav-
ing a visibly darker appearance in suspension. In the case
of the serum-containing medium, EMEM/S+, sedimenta-
tion was less apparent. AuNP Au[(Gly-Tyr-TrCys)2B],
along with Au[(Met)2B] and Au[(TrCys)2B], had a visibly
darker appearance, thereby suggesting different dispersion
rates for these particles when serum was present.
Toxicity studies
Interference of AuNPs with toxicity assays
AuNP concentration-dependent interference was detected
with the toxicity assays used in this study (Figure 9). In the
case of the commonly used MTT and NRU assays, absorb-
ance is used as the assay readout. Concentration-dependent
interference by control samples containing AuNPs without
cells was observed at both of the wavelengths used, 570 and
Figure 4 FT-IR spectra for free PBHs and PBH-capped AuNPs. (a) Free PBH (Gly-Tyr-Met)2B (bottom) and AuNP Au[(Gly-Tyr-Met)2B] (top),
(b) free PBH (Gly-Trp-Met)2B (bottom) and AuNP Au[(Gly-Trp-Met)2B] (top) and (c) free PBH (Met)2B (bottom) and AuNP Au[(Met)2B] (top).
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wavelengths (Figure 9a,b). A concentration-dependent in-
crease in absorbance levels was evident from a 6.25 μg/ml
exposure concentration, which reached a 500% increase at
the highest concentration used in this study (100 μg/ml) for
both wavelengths. The removal of the media and washing
with PBS did not lead to a significant reduction in interfer-
ences to levels that permitted the assays to be used appro-
priately. To combat interferences seen using absorbance as
endpoint readout, a cytotoxicity assay using resazurin
and its fluorescent product was applied. AuNP-only con-
trols suspended in EMEM medium were included and
interference was detected. We observed a concentration-
dependent decrease in the levels of fluorescence as a result
of AuNP interference (Figure 9c). At the highest concentra-
tion of AuNP, levels decreased by 11% to 24% depending
on the AuNP in question. Au[(Gly-Tyr-TrCys)2B] exhibited
the highest level of interference. The results were in-
terpreted with care in order to avoid drawing erroneous
conclusions. Cytotoxicity was assumed only when the de-
crease in fluorescence was lower than possible interference
levels. We also examined whether the AuNPs used in this
study interacted with the glutathione assay. AuNPs
absorbed at the wavelength used in this assay (405 nm). A
dose-dependent increase appeared for some of them at
concentrations of 1.56 μg/ml (data not shown) or higher.Additionally, when glutathione was incubated with a range
of AuNP concentrations for 2 h the level of free glutathi-
one decreased as the concentration of AuNPs increased
(Figure 9d). Therefore, this assay was not considered suit-
able for studying the oxidative stress potential of the
AuNPs. However, no interference was observed with the
ROS production assay (data not shown).
Cytotoxicity
Methyl thiazol tetrazolium and neutral red uptake as-
says The MTT and NRU assays could not be performed
as there was AuNP interference at the wavelengths used
in these tests (570 and 550 nm, respectively) (Figure 9a,b).
Resazurin assay Cytotoxicity assays were performed with
cells incubated in EMEM/S+ and EMEM/S- after 24- and
48-h exposure periods. Only results with cells incubated
in EMEM/S- are shown in Table 3, as clear evidence of
cytotoxicity in cells exposed to AuNPs in EMEM/S+ could
not be determined because of high interference levels in
this assay under these conditions (Figure 9c). Cytotoxicity
is expressed as percentage of live cells (viability) compared
to the untreated control (100%). At the highest concentra-
tion (100 μg/ml), all AuNP preparations caused approxi-
mately 10% decrease in viability. This was the highest
decrease in viability recorded after 24 h of incubation for
Figure 5 UV–vis absorption spectra of AuNPs. (a) Au[(Gly-Tyr-Met)2B], (b) Au[(Gly-Tyr-TrCys)2B], (c) Au[(Gly-Trp-Met)2B], (d) Au[(Met)2B] and
(e) Au[(TrCys)2B], in water and EMEM/-, each at a concentration of 100 μg/ml and at time point 0 and 2, 4 and 24 h of incubation at 37°C.
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was not higher than that recorded for the cell-free AuNP-
only controls in the interference studies (11% to 24% de-
crease). Therefore, the reduction in viability is perceived
to be a result of NP interference and cannot be reported
as cytotoxicity. After 48 h of incubation, the level of cyto-
toxicity for Au[(Gly-Tyr-Met)2B], Au[(Met)2B] and Au
[(TrCys)2B] increased significantly for the two highest
doses of 50 and 100 μg/ml (p < 0.01). Viability was re-
duced to levels beyond which AuNP interference may be
responsible. A significant decrease (p < 0.01) in cell viabil-
ity was observed for the AuNP Au[(Gly-Trp-Met)2B] only
at the highest dose (100 μg/ml). Exposure to AuNP Au
[(Gly-Tyr-TrCys)2B] also resulted in a reduction in viabilityover time but not below interference levels. This observa-
tion thus suggests that this AuNP presents increased
biocompatibility.
Images of cell condition An optical microscope was
used to view the cells and NPs in EMEM/S- at various
time points throughout the exposure. The study was
performed only for exposures using EMEM/S- because of
evidence of higher instability and toxicity of AuNPs under
these conditions. Figure 10 shows Hep G2 cells after 24 h
of incubation with NP concentrations of 100 μg/ml. The
AuNPs Au[(Met)2B] formed large agglomerates that cov-
ered almost the entire well (Figure 10f). While this
phenomenon made it difficult to view the cells, evidence
Table 2 Physico-chemical properties of PBH-capped AuNPs (100 μg/ml) under different conditions over time
Milli-Q water EMEM/S+ EMEM/S-
T0 T24 T0 T0 T24 T0 T24
AuNP Sizea Size Zetab Size Size Size Size
nm nm mV nm nm nm nm
Au[(Gly-Trp-Met)2B] 148 ± 2 148 ± 1 −31.6 ± 2.0 242 ± 4 243 ± 6 233 ± 15 1,239 ± 26
Au[(Gly-Tyr-TrCys)2B] 143 ± 1 143 ± 1 −37 ± 1.4 261 ± 1 261 ± 2 251 ± 15 195 ± 2
Au[(Gly-Tyr-Met)2B] 591 ± 73 507 ± 65 −36 ± 1.1 987 ± 205 987 ± 207 407 ± 21 1,230 ± 8
161 ± 5 150 ± 12 203 ± 13 201 ± 9
Au[(Met)2B] 229 ± 23 228 ± 10 −39 ± 1.1 190 ± 13 190 ± 4 1568 ± 28 1,368 ± 25
38 ± 6 40 ± 3 27 ± 9 28 ± 3
Au[(TrCys)2B] 205 ± 1 205 ± 1 −43.2 ± 1.1 261 ± 3 260 ± 4 271 ± 23 908 ± 23
97 ± 3
T0 represents measurements directly after preparation and T24 measurements 24 h after incubation under cell exposure conditions (37°C, 5% CO2). Average
values of three independent measurements are presented (mean ± SD). Bold emphasis is used to signal the most stable AuNP; DLS, dynamic light scattering.
aHydrodynamic size (Size); bzeta potential (Zeta) of AuNPs in Milli-Q water.
Figure 6 Size distribution of the PBH-capped AuNP
preparations (100 μg/ml) in EMEM/S- over time using DLS.
Maximum intensity hydrodynamic diameter (nm) measured directly
after preparation (T0) and at 2 h (T2), 4 h (T4), 24 h (T24) and 48 h
(T48) of incubation are shown.
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treated cells (Figure 10a). However, the cells most dramatic-
ally affected were those exposed to Au[(Gly-Tyr-TrCys)2B]
and Au[(TrCys)2B] (Figure 10d,g, respectively). Unique
and distinct dark assemblages in the cells exposed to Au
[(Gly-Tyr-TrCys)2B] (Figure 10d) were evident. The size of
Au[(Gly-Tyr-TrCys)2B] agglomerates did not permit NP
visualisation in a cell-free Au[(Gly-Tyr-TrCys)2B] suspen-
sion (Figure 8). This observation led us to believe that the
assemblies, visible when Au[(Gly-Tyr-TrCys)2B] was in
contact with cells (Figure 10d), are a result of cell damage
or are formed from cellular interaction with these AuNPs.
The cells exposed to Au[(TrCys)2B] (Figure 10g) showed
the characteristic appearance of cells treated with
chloramine-T (Figure 10b), the chemical used in this study
as a positive control. The cells rounded completely into a
blister-like structure. However, the AuNPs did not appear
to interact with the cells and instead were suspended in
the medium. The morphology of Hep G2 cells incubated
with Au[(Gly-Trp-Met)2B] was comparable with that of
untreated cells, despite the presence of some dark assem-
blages (Figure 10c). Cells exposed to Au[(Gly-Tyr-Met)2B]
(Figure 10e) also seemed to retain healthy cellular features,
with NPs settled on clear areas of the 96-well plate,
thereby suggesting limited NP-cellular interaction.
Oxidative stress
Quantification of reactive oxygen species A con-
centration-dependent increase in ROS in Hep G2 cells
exposed to the two highest doses (50 and 100 μg/ml) of
AuNPs in EMEM/S- was evident and significant as early
as 2 h and increased after 24 h of exposure (Figure 11a,b).
Exposure to Au[(Gly-Tyr-TrCys)2B] for 24 h produced
the highest increase in ROS levels, showing a 150% in-
crease after exposure to the highest concentration tested
(100 μg/ml) (Figure 11b). Au[(Gly-Tyr-Met)2B] showedthe lowest oxidative potential, with only a 40% increase in
ROS level after 24 h of exposure. Exposure assays after 24 h
using EMEM/S+ (Figure 11c) led to a reduction in ROS
production in Hep G2 cells in comparison with EMEM/
S- for all AuNP preparations after the same period. Most
dramatically, the capacity of Au[(Gly-Trp-Met)2B] and Au
[(Met)2B] to elicit ROS generation disappeared while the
ability of Au[(Gly-Tyr-TrCys)2B], Au[(Gly-Tyr-Met)2B]
and Au[(TrCys)2B] to elicit an oxidative stress response
was attenuated, with a significant difference in responses,
as measured statistically.
Reduced glutathione/oxidised glutathione ratio This
assay could not be performed due to AuNP interference
with the system (Figure 9d). There is a concentration-
Figure 7 TEM images of AuNPs in EMEM/S- after preparation. (a) Au[(TrCys)2B], (c) Au[(Gly-Tyr-TrCys)2B] and (e) Au[(Gly-Tyr-Met)2B], and at
24 h of incubation; (b) Au[(TrCys)2B], (d) Au[(Gly-Tyr-TrCys)2B] and (f) Au[(Gly-Tyr-Met)2B] [Scale bar (c) and (d) is 20 nm, and for all other images,
scale bar is 50 nm]; asterisk and bold letters are used to signal the most stable AuNP.
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Figure 8 PBH-capped AuNPs (100 μg/ml) after 24-h incubation in EMEM/S- as viewed using optical microscope. (a) Au[(Gly-Trp-Met)2B],
(b) Au[(Gly-Tyr-TrCys)2B], (c) Au[(Gly-Tyr-Met)2B, (d) Au[(Met)2B and (e) Au[(TrCys)2B]; asterisk and bold letters are used to signal the most
stable AuNP.
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DTNB to TNB caused by the interaction of the AuNPs
with glutathione.
Discussion
In this study, we have made some important observations
concerning the biological behaviour of PBH-capped
AuNPs. Depending on the structure of the PBH capping
ligand, the behaviour of AuNPs differed both in terms of
stability and biocompatibility. The PBH-capped AuNPs
used in this study associated in different ways, forming ag-
glomerates of different sizes under culture conditions, as
demonstrated through DLS measurements, UV–vis ana-
lysis and optical imaging. The stability of these particles
over time is dictated by both the structure of the PBH lig-
and and the surrounding medium. Even the smallest of
changes in ligand structure can lead to great differences in
AuNP behaviour. We detected clear differences in the
hydrodynamic size of AuNPs in EMEM/S+ and EMEM/S-.
In the former, all the AuNP preparations experienced a
uniform increase in hydrodynamic size, possibly because
of serum coating forming a corona, as proposed for otherNPs [54,55], but these preparations remained in a stable
size distribution over 24 h. It would appear that the serum
coating prevented further interaction between the individ-
ual AuNPs over time. In agreement with this finding,
Ehrenberg et al. [56] demonstrated protein binding to poly-
styrene particles (100 nm) with COOH functional groups
within seconds with stable protein-coated NPs after as little
as 30 min and these NPs remained stable for the entire test
period (4 h). According to our UV–vis and DLS analyses,
all PBH-capped AuNPs form stable agglomerates under
culture conditions when serum was present. However, con-
siderations are needed when serum is not present. In this
case, the structure of the PBH greatly influences the stabil-
ity and biocompatibility of the AuNP. In EMEM/S-, the
characteristic hydrodynamic size distribution profiles of all
the NP preparations increased considerably in a time-
dependent manner, with the exception of Au[(Gly-Tyr-
TrCys)2B]. This PBH-capped AuNP had the same hydro-
dynamic size distribution profile range (150 to 260 nm)
in EMEM/S- as in a water suspension and in medium
containing serum. Thus, the hydrodynamic size decreased
approximately 40 nm upon incubation. This reveals that
Figure 9 PBH-capped AuNP interference with the toxicity assays. (a) MTT, (b) neutral red uptake (NRU), (c) resazurin-based cytotoxicity assay
and (d) glutathione detection.
Table 3 Cytotoxicity of PBH-capped AuNPs following 24- and 48-h exposure (EMEM/S-), using resazurin assay
Exposure concentration (μg/ml)
Exposure duration AuNP 12.5 25 50 100
Au[(Gly-Trp-Met)2B] 24 h 97 ± 1 97 ± 1* 96 ± 1* 94 ± 0.3**
a
Viability (%) 48 h 98 ± 1 98 ± 2 91 ± 1 69 ± 4**a
Measured interference (%) 96 ± 2 95 ± 2 94 ± 4 88 ± 4
Au[(Gly-Tyr-TrCys)2B] 24 h 98 ± 1 96 ± 1* 93 ± 1** 90 ± 1**
Viability (%) 48 h 95 ± 2 100 ± 2 95 ± 3 87 ± 2*
Measured interference (%) 96 ± 3 90 ± 6 85 ± 7 76 ± 6
Au[(Gly-Tyr-Met)2B] 24 h 96 ± 1 96 ± 1* 96 ± 1* 91 ± 2**
a
Viability (%) 48 h 94 ± 1 91 ± 6* 81 ± 6** 71 ± 5**a
Measured interference (%) 95 ± 2 92 ± 2 90 ± 4 88 ± 4
Au[(Met)2B] 24 h 97 ± 1 96 ± 0.4* 93 ± 0.4** 94 ± 2**
a
Viability (%) 48 h 97 ± 1 91* ± 3 88 ± 4** 68 ± 4 **a
Measured interference (%) 93 ± 1 91± 91 ± 2 89 ± 5
Au[(TrCys)2B] 24 h 98 ± 1 97 ± 1 92 ±2* 88 ± 1**
Viability (%) 48 h 94 ± 4 93 ± 1 88 ± 2 ** 77 ± 1**
Measured interference (%) 95 ± 1 93± 91 ± 3 87 ± 4
Also shown are the measured interferences in percent (%) of the control. Average values of three independent measurements are presented (mean ± SEM). Bold
emphasis is used to signal the most stable AuNP; *P < 0.05 and **P < 0.01, significant differences from control values. aSignificant differences between response
to 24- and 48-h exposure.
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Figure 10 Optical microscope images of the morphology of Hep G2 cells. (a) untreated (b) after 24-h incubation with chloramine-T
(positive control) and after 24-h exposure to AuNP preparations (c) Au[(Gly-Trp-Met)2B], (d) Au[(Gly-Tyr-TrCys)2B], (e) Au[(Gly-Tyr-Met)2B], (f) Au
[(Met)2B] and (g) Au[(TrCys)2B] in EMEM/S-; asterisk and bold letters are used to signal the most stable AuNP.
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[(Gly-Tyr-TrCys)2B]. Interestingly, sizes up to micron scale
were recorded for Au[(Met)2B] (1,568 nm) almost immedi-
ately upon contact with the EMEM/S- medium. UV–vis
analysis of this AuNP suspension over time revealed red
shifts in the SPR band, with a slight broadening, suggesting
agglomeration of NPs in that medium. For Au[(Gly-Trp-
Met)2B], Au[(Gly-Tyr-Met)2B] and Au[(Met)2B], which
contain methionine, a minimal decrease in the intensity
band was observed over time, probably caused by the ad-
sorption of amino acids of the culture medium. In contrast,
in the UV–vis spectrum of Au[(Gly-Tyr-TrCys)2B], the de-
crease in the intensity of SPR band was not observed,
suggesting that the steric bulk and the strong interaction of
(Gly-Tyr-TrCys)2B with the gold prevents the adsorption of
compounds from culture medium. Only after 24-h incuba-
tion, the UV–vis spectrum shows a shoulder in the range
of 550 to 800 nm. It seems that the aggregation process oc-
curs slower than in other samples. AuNP agglomeration
and interaction with medium over time was also confirmed
with TEM analysis.
Differences in the structure of the PBH capping agents
used in this study led to distinct associations between in-
dividual AuNPs and their environment. The stability of
Au[(Gly-Tyr-TrCys)2B] and Au[(Gly-Tyr-Met)2B] dif-
fered in cell culture conditions. This difference could beattributed to the stabilising effect of the TrCys group in
comparison with the Met group. TrCys and Met resi-
dues are involved in binding to the gold surface. The
higher binding of the PBH (Gly-Tyr-TrCys)2B to the
gold in comparison with the PBH (Gly-Tyr-Met)2B is
due to the additional aromatic interactions of the TrCys
residue. The bulkier group, TrCys, may contribute to
protecting individual NPs from assembling into larger
agglomerates, thereby leading to the stability of Au[(Gly-
Tyr-TrCys)2B] agglomerates. In addition, as revealed by
elemental analysis, Au[(Gly-Tyr-TrCys)2B] was stabilised
by 40 PBH units in comparison with 7 PBH units for Au
[(Gly-Tyr-Met)2B]. Similar considerations can be made
for Au[(TrCys)2B] and Au[(Met)2B]. Au[(TrCys)2B] was
stable up to 4 h and formed smaller agglomerates over
time compared to Au[(Met)2B]. The stabilisation of Au
[(TrCys)2B] was achieved with 97 PBH units compared
to 57 units for Au[(Met)2B]. It appears that the TrCys
group also conferred stability upon Au[(TrCys)2B]. Overall,
these findings suggest that the TrCys residue and the steric
bulk of PBH (Gly-Tyr-TrCys)2B are responsible for the re-
markable stability of Au[(Gly-Tyr-TrCys)2B] agglomerates.
The observations reported here have a major implication
for the use of specific PBH capping agents in nanomaterial
science. By applying PBH capping agents with different
structures, the physico-chemical properties of AuNPs
Figure 11 Comparison of oxidative stress response in Hep G2 cell line. (a) Two and (b) 24 h of exposure to AuNP under EMEM/S- and
(c) after 24 h of exposure to EMEM/S+ assay conditions. Average values of three independent measurements are presented (mean ± SEM).
Significant differences from control values are shown (*P < 0.05, **P < 0.01). α indicates significant differences between responses, as shown by
pair-wise comparison analysis.
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environments.
Interestingly, we observed that the two PBH-capped
AuNPs that showed increased stability, namely Au[(Gly-
Tyr-TrCys)2B] and Au[(TrCys)2B], also produced the
highest increase in ROS levels. However, significant ROS
production was detected only at the two highest doses
(50 and 100 μg/ml), thus indicating the feasibility of use
at lower concentrations. Oxidative stress induction has
been proposed as the principal mechanism of toxicity
for many forms of NPs [57-59], including AuNPs [60].
Although the exact biological mechanism behind the ac-
tion of the AuNPs was not determined in this study, we
reveal that they all have the capacity to produce increased
levels of ROS. However, the extent of this productiondiffered depending on the PBH structures attached to the
AuNP and the medium environment. ROS levels twofold
higher than control levels were recorded after exposure to
100 μg/ml Au[(Gly-Tyr-TrCys)2B]. In contrast, exposure
to the same concentration of Au[(Gly-Tyr-Met)2B] elicited
only a slight increase in ROS production, which was 50%
higher than control levels. The presence or absence of
serum also influenced the oxidative stress response to the
PBH-capped AuNPs. Those that caused the highest in-
crease in ROS levels in EMEM/S- had a significantly at-
tenuated capacity to induce ROS in the Hep G2 cells in
EMEM/S+ medium. For instance, Au[(Gly-Tyr-TrCys)2B]
AuNPs elicited the highest levels of ROS in EMEM/S-,
and this effect was weakened in EMEM/S+, despite this
NP having the same size distribution in both mediums
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ated ROS induction observed for all the NPs in EMEM/S+
is not related to size but specifically to serum coating.
Merhi et al. [61] showed that endocytosis decreases when
NPs are exposed to increasing concentrations of fetal calf
serum and bovine serum albumin.
How the AuNPs interact with the cells or whether the
different PBH capping agents influence the capacity of
the particles to enter cells were not addressed exten-
sively in this study. However, some observations and re-
marks can be made on the basis of our results. It is
known that differently charged functional groups have
different associations with cells. In this study, all zeta po-
tentials were negative due to the presence of carboxylate
(COO−) groups on the attached peptide-biphenyl coat-
ings. Using silica NPs modified with amine and carboxyl
functional groups and the murine macrophage cell line
(RAW264.7), Nabeshi et al. [62] showed that while
amine-functionalised silica NPs absorbed to the plasma
membrane, carboxyl functionalities penetrated deeper
intracellularly. This finding would suggest that these
carboxyl groups bury themselves inside the cell mem-
brane. Thus, the increased biological activity of Au[(Gly-
Tyr-TrCys)2B] may be explained not only by its stability,
remaining in individual AuNP agglomerates of approxi-
mately 200 nm in size but also by the presence of free
carboxyl groups interacting with cellular components. In
addition, studies show that the aromatic structures of
tyrosine residues are important regulators of NP cellular
uptake (referred to as the aromatic structure hypothesis)
[63]. According to these studies, the tyrosine residues in
the PBH cap of Au[(Gly-Tyr-TrCys)2B] NPs might en-
hance the cellular uptake. Using Hep G2 cells, Yuan
et al. [64] demonstrated that hydroxyapatite NPs as large
as 175 nm are taken up by the cells but do not penetrate
the nuclear membrane and are confined to the peri-
nuclear region. However, Johnston et al. [65], who also
studied the uptake and intracellular fate of NPs in Hep
G2 cells, came to the conclusion that the internalisation
of 200 nm negatively charged carboxylated polystyrene
NPs was limited because of size.
If the PBH-capped AuNPs are taken up, their strong
affinity for GSH, together with the significant increase in
ROS production, as illustrated in this study, would sug-
gest that the AuNPs act on the same mechanism of oxi-
dative stress as that proposed by Gao et al. [66]. These
authors hypothesised that AuNP-induced oxidative
stress in the HL7702 human liver cell line is related to
the binding of these NPs to endogenous antioxidants
(GSH), leading to complete depletion after 48 h. The in-
crease in surface area associated with the decrease in
size allows for more GSH binding and thus depletion.
They also reported that the extent of oxidative stress de-
pends on NP access to cytosolic GSH or mitochondrialGSH reserves. Hence, increased oxidative stress may
occur with smaller NPs. This notion would explain the
different levels of ROS production observed in this
study, in particular the higher ROS levels elicited by Au
[(Gly-Tyr-TrCys)2B] (the AuNPs present in the smallest
hydrodynamic size, as shown by DLS).
Evidence of dark assemblies in Hep G2 cells exposed
to AuNP Au[(Gly-Tyr-TrCys)2B] would suggest cellular
interaction/internalisation; however, further studies are
needed. Cells undergoing autophagy have clearly visible
autophagosomes, which form around degraded cellular
components. The dark assemblages present in Hep G2
cells after exposure to Au[(Gly-Tyr-TrCys)2B] resemble
these autophagosomes. Li et al. [67] proposed a cell sur-
vival mechanism of autophagy upon exposure to AuNPs.
This mechanism has been studied further by Ma et al.
[68], who showed that AuNPs that are taken up and ac-
cumulate in lysosomes induce autophagosome accumu-
lation through the blockage of the autophagy flux. This
observation supports the findings in this study for Au
[(Gly-Tyr-TrCys)2B]. In this case, despite the high levels
of ROS produced, the cells did not succumb to the same
loss in viability as that registered for the other NPs at 48
h of exposure. This phenomenon was observed only for
cells exposed to the AuNP Au[(Gly-Tyr-TrCys)2B], thus
suggesting that the unique state of this NP in the culture
medium influences the NP-cell interaction.
In fact, AuNPs eliciting the lowest increase in ROS levels
after 24 h also showed the greatest loss in viability after 48
h of incubation: exposure to Au[(Gly-Trp-Met)2B], Au
[(Gly-Tyr-Met)2B] and Au[(Met)2B] reduced viability to
69%, 71% and 68%, respectively. These AuNPs all formed
large agglomerates and had Met groups in their PBH-
capping agents.
Several considerations need to be made when studying
NP toxicity. One must be aware that NPs may interact un-
favourably with assay components. The AuNPs described
herein absorb at the same wavelength as those used for
the MTT cytotoxicity assay (570 nm) and NRU assay (550
nm). NP interferences with commonly used toxicity as-
says, such as NRU and MTT, have been reported previ-
ously [69,70]. In addition, AuNP interference was also
observed when carrying out the GSH/GSSG ratio assay.
Care should be taken when interpreting results in order to
avoid false positive results. One should also consider that
the physico-chemical state of the NP under distinct assay
conditions may also lead to differences in levels of interfer-
ence. All of these factors must not be overlooked.
Conclusions
Here, we prepared AuNPs using several PBHs as capping
agents and studied the influence of the structure of these
agents on the physico-chemical state and biocompatibility
of the resulting NPs. All the AuNPs tested showed excellent
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culture conditions when serum was present. One PBH-
capped AuNP preparation, namely (Au[(Gly-Tyr-TrCys)
2B]), showed unique physico-chemical properties present-
ing agglomerates (approximately 200 nm) that remained in
the same size distribution under cell culture conditions as
when suspended in water, even in the absence of serum.
Interestingly, these AuNPs elicited the highest oxidative
stress response, with evidence of a unique biological inter-
action that did not lead to a reduction in Hep G2 cell via-
bility after 48 h of exposure. Our findings suggest that these
particular PBH-capped AuNPs exerts a distinct effect on
the Hep G2 cell line that is governed by their particular
conformation, which is controlled by the chemical structure
of their capping agent (Gly-Tyr-TrCys)2B. Given the dis-
tinct cellular morphology after exposure to these AuNPs
and previous reports of AuNP mechanisms of interactions
with biological systems, we propose that the Hep G2 cells
undergo a cell survival mechanism of autophagy upon ex-
posure to these AuNPs, thus supporting the notion of a cel-
lular interaction/internalisation of these AuNPs. Given the
relevance of interaction/internalisation, further research ef-
forts should address the applicability of these AuNPs in
drug delivery systems.
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